Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization.

Mar J, Arrospide A, Soto-Gordoa M, Iruin Á, Tainta M, Gabilondo A, Mar-Barrutia L, Calvo M, Mateos M, Ibarrondo O.

Neuropsychiatr Dis Treat. 2019 Jul 17;15:2027-2034. doi: 10.2147/NDT.S209008. eCollection 2019.

2.

Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.

Kim M, Snowden S, Suvitaival T, Ali A, Merkler DJ, Ahmad T, Westwood S, Baird A, Proitsi P, Nevado-Holgado A, Hye A, Bos I, Vos S, Vandenberghe R, Teunissen C, Ten Kate M, Scheltens P, Gabel S, Meersmans K, Blin O, Richardson J, De Roeck E, Sleegers K, Bordet R, Rami L, Kettunen P, Tsolaki M, Verhey F, Sala I, Lléo A, Peyratout G, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Engelborghs S, Frisoni GB, Molinuevo JL, Wallin A, Popp J, Martinez-Lage P, Bertram L, Barkhof F, Ashton N, Blennow K, Zetterberg H, Streffer J, Visser PJ, Lovestone S, Legido-Quigley C.

Alzheimers Dement. 2019 Jun;15(6):817-827. doi: 10.1016/j.jalz.2019.03.004. Epub 2019 May 8.

3.

Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.

Lleó A, Alcolea D, Martínez-Lage P, Scheltens P, Parnetti L, Poirier J, Simonsen AH, Verbeek MM, Rosa-Neto P, Slot RER, Tainta M, Izaguirre A, Reijs BLR, Farotti L, Tsolaki M, Vandenbergue R, Freund-Levi Y, Verhey FRJ, Clarimón J, Fortea J, Frolich L, Santana I, Molinuevo JL, Lehmann S, Visser PJ, Teunissen CE, Zetterberg H, Blennow K.

Alzheimers Dement. 2019 Jun;15(6):742-753. doi: 10.1016/j.jalz.2019.01.015. Epub 2019 Apr 6.

PMID:
30967340
4.

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.

Bos I, Vos S, Verhey F, Scheltens P, Teunissen C, Engelborghs S, Sleegers K, Frisoni G, Blin O, Richardson JC, Bordet R, Tsolaki M, Popp J, Peyratout G, Martinez-Lage P, Tainta M, Lleó A, Johannsen P, Freund-Levi Y, Frölich L, Vandenberghe R, Westwood S, Dobricic V, Barkhof F, Legido-Quigley C, Bertram L, Lovestone S, Streffer J, Andreasson U, Blennow K, Zetterberg H, Visser PJ.

Alzheimers Dement. 2019 May;15(5):644-654. doi: 10.1016/j.jalz.2019.01.004. Epub 2019 Mar 8.

PMID:
30853464
5.

Isopropanol extraction for cerebrospinal fluid lipidomic profiling analysis.

Iriondo A, Tainta M, Saldias J, Arriba M, Ochoa B, Goñi FM, Martinez-Lage P, Abad-García B.

Talanta. 2019 Apr 1;195:619-627. doi: 10.1016/j.talanta.2018.11.101. Epub 2018 Nov 29.

PMID:
30625592
6.

Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid.

Lleó A, Núñez-Llaves R, Alcolea D, Chiva C, Balateu-Paños D, Colom-Cadena M, Gomez-Giro G, Muñoz L, Querol-Vilaseca M, Pegueroles J, Rami L, Lladó A, Molinuevo JL, Tainta M, Clarimón J, Spires-Jones T, Blesa R, Fortea J, Martínez-Lage P, Sánchez-Valle R, Sabidó E, Bayés À, Belbin O.

Mol Cell Proteomics. 2019 Mar;18(3):546-560. doi: 10.1074/mcp.RA118.001290. Epub 2019 Jan 3.

PMID:
30606734
7.

Longitudinal Neuropsychological Study of Presymptomatic c.709-1G>A Progranulin Mutation Carriers.

Barandiaran M, Moreno F, de Arriba M, Indakoetxea B, Boda I, Gabilondo A, Tainta M, López de Munain A.

J Int Neuropsychol Soc. 2019 Jan;25(1):39-47. doi: 10.1017/S1355617718000735. Epub 2018 Oct 29.

PMID:
30369339
8.

The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients.

Sáenz-Cuesta M, Alberro A, Muñoz-Culla M, Osorio-Querejeta I, Fernandez-Mercado M, Lopetegui I, Tainta M, Prada Á, Castillo-Triviño T, Falcón-Pérez JM, Olascoaga J, Otaegui D.

Int J Mol Sci. 2018 Aug 19;19(8). pii: E2448. doi: 10.3390/ijms19082448.

9.

Increased CAIDE dementia risk, cognition, CSF biomarkers, and vascular burden in healthy adults.

Ecay-Torres M, Estanga A, Tainta M, Izagirre A, Garcia-Sebastian M, Villanua J, Clerigue M, Iriondo A, Urreta I, Arrospide A, Díaz-Mardomingo C, Kivipelto M, Martinez-Lage P.

Neurology. 2018 Jul 17;91(3):e217-e226. doi: 10.1212/WNL.0000000000005824. Epub 2018 Jun 13.

PMID:
29898969
10.

Advances on Automatic Speech Analysis for Early Detection of Alzheimer Disease: A Non-linear Multi-task Approach.

Lopez-de-Ipina K, Martinez-de-Lizarduy U, Calvo PM, Mekyska J, Beitia B, Barroso N, Estanga A, Tainta M, Ecay-Torres M.

Curr Alzheimer Res. 2018;15(2):139-148. doi: 10.2174/1567205014666171120143800.

PMID:
29165084
11.

Cortical microstructural changes along the Alzheimer's disease continuum.

Montal V, Vilaplana E, Alcolea D, Pegueroles J, Pasternak O, González-Ortiz S, Clarimón J, Carmona-Iragui M, Illán-Gala I, Morenas-Rodríguez E, Ribosa-Nogué R, Sala I, Sánchez-Saudinós MB, García-Sebastian M, Villanúa J, Izagirre A, Estanga A, Ecay-Torres M, Iriondo A, Clerigue M, Tainta M, Pozueta A, González A, Martínez-Heras E, Llufriu S, Blesa R, Sanchez-Juan P, Martínez-Lage P, Lleó A, Fortea J.

Alzheimers Dement. 2018 Mar;14(3):340-351. doi: 10.1016/j.jalz.2017.09.013. Epub 2017 Oct 31.

PMID:
29080407
12.

The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristics.

Moreno F, Indakoetxea B, Barandiaran M, Caballero MC, Gorostidi A, Calafell F, Gabilondo A, Tainta M, Zulaica M, Martí Massó JF, López de Munain A, Sánchez-Juan P, Lee SE.

PLoS One. 2017 Jun 8;12(6):e0178093. doi: 10.1371/journal.pone.0178093. eCollection 2017.

13.

Nontraditional Lipid Variables Predict Recurrent Brain Ischemia in Embolic Stroke of Undetermined Source.

de la Riva P, Zubikarai M, Sarasqueta C, Tainta M, Muñoz-Lopetegui A, Andrés-Marín N, González F, Díez N, de Arce A, Bergareche A, Lopez de Munain A, Martínez-Zabaleta M.

J Stroke Cerebrovasc Dis. 2017 Aug;26(8):1670-1677. doi: 10.1016/j.jstrokecerebrovasdis.2017.03.024. Epub 2017 Apr 13.

PMID:
28412318
14.

[Rhomboencephalitis and endocarditis caused by Listeria monocytogenes: an unreported association].

Tainta M, de la Riva P, Gonzalez F, Marti-Masso JF, Goenaga MA.

Rev Neurol. 2016 Jul 1;63(1):46-8. Spanish. No abstract available.

15.

Reversible delayed post-hypoxic leukoencephalopathy.

Tainta M, de la Riva P, Urtasun MÁ, Martí-Massó JF.

Neurologia. 2018 Jan - Feb;33(1):59-61. doi: 10.1016/j.nrl.2015.11.011. Epub 2016 Jan 13. English, Spanish. No abstract available.

16.

Coupling between beta and high-frequency activity in the human subthalamic nucleus may be a pathophysiological mechanism in Parkinson's disease.

López-Azcárate J, Tainta M, Rodríguez-Oroz MC, Valencia M, González R, Guridi J, Iriarte J, Obeso JA, Artieda J, Alegre M.

J Neurosci. 2010 May 12;30(19):6667-77. doi: 10.1523/JNEUROSCI.5459-09.2010.

17.

HLA-DR2 and white matter lesion distribution in MS.

Sepulcre J, Masdeu JC, Palacios R, Goñi J, Moreno B, Tainta M, Bejarano B, Villoslada P.

J Neuroimaging. 2008 Jul;18(3):328-31. doi: 10.1111/j.1552-6569.2008.00259.x. Epub 2008 May 8.

PMID:
18482373

Supplemental Content

Loading ...
Support Center